PMID- 15689417 OWN - NLM STAT- MEDLINE DCOM- 20050801 LR - 20161124 IS - 1096-6080 (Print) IS - 1096-0929 (Linking) VI - 85 IP - 1 DP - 2005 May TI - Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. PG - 541-50 AB - Arsenic exposure is associated with an increased risk of vascular disorders, and results in increased oxidative stress in endothelial cells and vascular smooth muscle cells (VSMCs). Since oxidative stress is involved in regulating the expression of genes related to atherogenesis, we investigated its involvement in the enhanced expression of three atherosclerosis-related genes coding for heme oxygenase-1 (HO-1), monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6) in VSMCs treated with inorganic sodium arsenite (iAs). In human VSMCs (hVSMCs) and rat VSMCs (rVSMCs), HO-1, MCP-1, and IL-6 mRNA levels were significantly increased by iAs treatment. An increase in HO-1 protein levels in hVSMCs was confirmed by Western blotting technique, while increased MCP-1 and IL-6 secretion by hVSMCs was demonstrated by enzyme-linked immunosorbent assay. Although modulators of oxidative stress inhibited this iAs-induced increase in the expression of these three genes, different modulators had differential effects. In iAs-treated rVSMCs, catalase, dimethylsulfoxide, and L-omega-nitro-L-arginine significantly inhibited the increase in expression of all three genes, allopurinol inhibited the increase in MCP-1 and IL-6 expression, but had no effect on HO-1 expression, while superoxide dismutase had no significant effect on HO-1 expression, but had an inhibitory effect on IL-6 expression and a stimulatory effect on MCP-1 expression. Therefore, iAs may enhance the expression of HO-1, MCP-1, and IL-6 in VSMCs via different reactive oxygen molecules. Furthermore, using tin protoporphyrin IX (SnPP) and anti-MCP-1 antibody to abolish iAs-induced HO-1 and MCP-1 activity, respectively, shows that HO-1 has protective effect against iAs-induced injury in VSMCs and MCP-1 is chemoattractive to human monocytes, THP-1. FAU - Lee, Pei-Chung AU - Lee PC AD - Institute of Biopharmaceutical Science, School of Life Sciences, National Yang-Ming University, Pei-Tou, Taipei, Taiwan, ROC. FAU - Ho, I-Ching AU - Ho IC FAU - Lee, Te-Chang AU - Lee TC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20050202 PL - United States TA - Toxicol Sci JT - Toxicological sciences : an official journal of the Society of Toxicology JID - 9805461 RN - 0 (Arsenites) RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-6) RN - 0 (Membrane Proteins) RN - 0 (Reactive Oxygen Species) RN - 0 (Sodium Compounds) RN - 48OVY2OC72 (sodium arsenite) RN - EC 1.14.14.18 (HMOX1 protein, human) RN - EC 1.14.14.18 (Heme Oxygenase (Decyclizing)) RN - EC 1.14.14.18 (Heme Oxygenase-1) SB - IM MH - Animals MH - Aorta MH - Arsenites/*toxicity MH - Cell Survival/drug effects MH - Cells, Cultured MH - Chemokine CCL2/genetics MH - Chemotaxis, Leukocyte/drug effects MH - Fibroblasts/drug effects/metabolism MH - Gene Expression/*drug effects MH - Heme Oxygenase (Decyclizing)/genetics MH - Heme Oxygenase-1 MH - Humans MH - Interleukin-6/genetics MH - Membrane Proteins MH - Monocytes/drug effects MH - *Muscle, Smooth, Vascular/cytology/drug effects/metabolism MH - Oxidative Stress/*drug effects MH - Rats MH - Reactive Oxygen Species/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Sodium Compounds/*toxicity EDAT- 2005/02/04 09:00 MHDA- 2005/08/02 09:00 CRDT- 2005/02/04 09:00 PHST- 2005/02/04 09:00 [pubmed] PHST- 2005/08/02 09:00 [medline] PHST- 2005/02/04 09:00 [entrez] AID - kfi101 [pii] AID - 10.1093/toxsci/kfi101 [doi] PST - ppublish SO - Toxicol Sci. 2005 May;85(1):541-50. doi: 10.1093/toxsci/kfi101. Epub 2005 Feb 2.